Memory, Learning and Cognition
Cognition is the term used to define the process of thoughts, including memory, awareness, reasoning and perception. Cognitive enhancement describes the improvement of the information processing systems of the mind and the extension of its main capacities, which can be undertaken simply by learning, especially during early development.
Memory, Learning and Cognition Products Targets
- Voltage-gated Calcium Channel (CaV) (38)
- Others (13)
- D4 Receptor (12)
- 5-HT7 Receptor (11)
- 5-HT6 Receptor (14)
- 5-ht5 Receptor (2)
- 5-HT4 Receptor (17)
- NOP Receptor (21)
- Mu-Opioid Receptors (15)
- Kappa Opioid Receptors (14)
- Glutamate (Metabotropic) Group III Receptor (26)
- Glutamate (Metabotropic) Group II Receptor (33)
- Glutamate (Metabotropic) Group I Receptor (54)
- AMPA Receptor (45)
- GABAA-ρ Receptor (8)
- GABAA Receptor (66)
- GPR55 (8)
- CB2 Receptor (6)
- CB1 Receptor (17)
- Nicotinic (α7) Receptor (25)
- Nicotinic (α4β2) Receptor (14)
- Protein Kinase C (29)
- Calmodulin-Dependent Kinase (8)
- D3 Receptor (12)
- NMDA Receptor (87)
- Kainate Receptor (22)
- D2 Receptor (14)
- D1 and D5 Receptor (16)
- Amyloid beta Peptide (28)
- Histamine H1 Receptor (17)
- M5 Receptor (2)
- M4 Receptor (3)
- M3 Receptor (4)
- M2 Receptor (5)
- M1 Receptor (8)
- Delta opioid receptor (16)
- Protein serine and threonine phosphatase (16)
- Histone Deacetylase (19)
- Phosphodiesterase (34)
Products for Memory, Learning and Cognition - Page 9
- Cat.No. Product Name Information/Activity
-
BCC7155
Enoximone
77671-31-9
-
BCC6648
Etazolate hydrochloride
35838-58-5
-
BCC7502
IBMX
IBMX is a broad-spectrum phosphodiesterase (PDE) inhibitor, with IC50s of 6.5, 26.3 and 31.7 μM for PDE3, PDE4 and PDE5, respectively.
-
BCC7188
ICI 63197
27277-00-5
-
BCC7066
MDL 12330A hydrochloride
Cyclic nucleotide PDE inhibitor; also adenylyl cyclase inhibitor
-
BCC7549
Mesopram
189940-24-7
-
BCC4374
Milrinone
Milrinone is a PDE3 inhibitor, and also an inotrope and vasodilator.
-
BCC6692
MMPX
78033-08-6
-
BCC6645
MY-5445
MY-5445 is a specific phosphodiesterase type 5 (PDE5) inhibitor. MY-5445 selectively inhibits cGMP PDE with a Ki of 1.3 μM.
-
BCC6215
Piclamilast
144035-83-6


